kras mutation and glutathion Frontiers Impact of KRAS mutation on
Impact of KRAS mutation on the tumor microenvironment in colorectal cancer Targeting KRAS mutant stomach colorectal tumors by disrupting the ERK2 p53 complex ScienceDirect Selective killing of cancer cells harboring mutant RAS by concomitant inhibition of NADPH oxidase and glutathione biosynthesis Cell Death & Disease The KRAS G12D mutation induces metabolic vulnerability in B cell acute lymphoblastic leukemia ScienceDirect Targeting KRAS Mutant Cancers with a Covalent G12C Specific Inhibitor: Cell
Pay in 4 interest-free payments of $6.13 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14




